BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that the

The U.S. Food and Drug Administration approved expanded use of Vertex Pharmaceuticals' gene therapy

Dyne Therapeutics focuses on high-potential therapies for rare neuromuscular diseases using its prop

Vertex Pharmaceuticals Incorporated maintains a dominant, monopoly position in cystic fibrosis, driv

TD Cowen analyst Jared Levine initiates coverage on Vertex (NASDAQ:VERX) with a Buy rating and an

One firm sees room for this tech stock to run.

CRISPR Therapeutics AG continues to pioneer gene-editing through its landmark CASGEVY therapy while

Citigroup analyst Steven Enders maintains Vertex (NASDAQ:VERX) with a Neutral and raises the pric

Piper Sandler analyst Billy Fitzsimmons maintains Vertex (NASDAQ:VERX) with a Neutral and raises

Vertex (NASDAQ:VERX) affirms FY2026 sales outlook from $823.500 million-$831.500 million to $823.500

Vertex (NASDAQ:VERX) reported quarterly earnings of $0.17 per share which met the analyst consensus

BMO Capital analyst Daniel Jester maintains Vertex (NASDAQ:VERX) with a Market Perform and lowers

Goldman Sachs analyst Adam Hotchkiss maintains Vertex (NASDAQ:VERX) with a Buy and lowers the pri

Citizens analyst Patrick Walravens maintains Vertex (NASDAQ:VERX) with a Market Outperform and lo

Piper Sandler analyst Billy Fitzsimmons maintains Vertex (NASDAQ:VERX) with a Neutral and lowers

Needham analyst Joshua Reilly maintains Vertex (NASDAQ:VERX) with a Buy and lowers the price targ

Goldman Sachs sees a familiar pattern returning in 2026: prior-year laggards often beat the S&P

After a rough start to the year, small- and mid-cap software stocks may be finding their footing. Go

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin

U.S. stocks traded lower, with the Nasdaq Composite falling around 100 points on Wednesday. Here are

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earni

Companies Reporting Before The Bell • Nomad Foods (NYSE:NOMD) is projected to report quarterly earn

Gainers Kimball International, Inc. (NASDAQ: KBAL) shares jumped 84.9% to $12.40 after HNI Corpor

Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earn

Gainers AGBA Group Holding Limited (NASDAQ: AGBA) gained 50.7% to close at $6.78 on Friday.

Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly ear

Upgrades

  Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to repor

  On Tuesday, 951 companies hit new 52-week lows.

  On Wednesday, 807 companies reached new 52-week lows.

  Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly

  Companies Reporting Before The Bell • REV Group (NYSE:REVG) is expected to report quarterly earn

    On Wednesday, 348 companies hit new 52-week lows.

    On Monday morning, 60 companies achieved new lows for the year.